Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Network Meta-Analysis Comparing the Efficacy of Therapeutic Treatments for Bronchiolitis in Children
Caili Guo1, Xiaomin Sun1, Xiaowen Wang1
1Department of Respiratory, Children's Hospital of Zhengzhou City, Zhengzhou, Henan, China.
Insights
Epinephrine with or without corticosteroids (EP ± CS) and epinephrine with or without hypertonic saline (EP ± HS) are recommended as the optimal bronchiolitis treatments for children, showing superior outcomes in clinical severity score and length of hospital stay.
Area of Science:
- Pediatric Pulmonology
- Critical Care Medicine
- Evidence-Based Medicine
Background:
- Bronchiolitis is a common pediatric respiratory infection.
- Optimal treatment strategies for bronchiolitis remain under investigation.
- Comparison of various therapeutic regimens is essential for evidence-based clinical practice.
Purpose of the Study:
- To compare placebo with seven therapeutic regimens for bronchiolitis treatment.
- To determine the optimal treatment for pediatric bronchiolitis.
- To evaluate efficacy based on clinical severity score (CSS) and length of hospital stay (LHS).
Main Methods:
- Network meta-analysis of 40 studies (1995-2016).
- Utilized mean difference and standardized mean difference with 95% credible intervals.
- Surface Under the Cumulative Ranking Curve (SUCRA) for therapy ranking.
Main Results:
- No significant difference between 7 regimens and placebo for CSS.
- Epinephrine with or without hypertonic saline (EP ± HS) and epinephrine with or without corticosteroids (EP ± CS) showed advantages for LHS over placebo and bronchodilator agents (BA).
- SUCRA identified EP ± CS as most effective for CSS, and EP ± HS as most effective for LHS.
Conclusions:
- EP ± CS and EP ± HS are recommended as first-line treatments for pediatric bronchiolitis.
- These regimens demonstrate superior performance in reducing clinical severity and hospital stay.
- Evidence supports the use of EP-based therapies for improved bronchiolitis management.
Background:
This study aims to compare placebo (PBO) and 7 therapeutic regimens-namely, bronchodilator agents (BAs), hypertonic saline (HS), BA ± HS, corticosteroids (CS), epinephrine (EP), EP ± CS, and EP ± HS-to determine the optimal bronchiolitis treatment.
Methods:
We plotted networks using the curative outcome of several studies and specified the relations among the experiments by using mean difference, standardized mean difference, and corresponding 95% credible interval. The surface under the cumulative ranking curve (SUCRA) was used to separately rank each therapy on clinical severity score (CSS) and length of hospital stay (LHS).
Results:
This network meta-analysis included 40 articles from 1995 to 2016 concerning the treatment of bronchiolitis in children. All 7 therapeutic regimens displayed no significant difference to PBO with regard to CSS in our study. Among the 7 therapies, BA performed better than CS. As for LHS, EP and EP ± HS had an advantage over PBO. Moreover, EP and EP ± HS were also more efficient than BA. The SUCRA results showed that EP ± CS is most effective, and EP ± HS is second most effective with regard to CSS. With regard to LHS, EP ± HS ranked first, EP ± CS ranked second, and EP ranked third.
Conclusions:
We recommend EP ± CS and EP ± HS as the first choice for bronchiolitis treatment in children because of their outstanding performance with regard to CSS and LHS.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Self-Efficacy
Directing Effect of Substituents: meta-Directing Groups
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
Therapeutic Drug Monitoring: Drug Analysis Methods

